- Home
- STIM vs OPP Comparison
STIM vs OPP Comparison
Compare STIM & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- OPP
- Stock Information
- Founded
- STIM 2003
- OPP 2010
- Country
- STIM United States
- OPP United States
- Employees
- STIM N/A
- OPP N/A
- Industry
- STIM Medical/Dental Instruments
- OPP Finance/Investors Services
- Sector
- STIM Health Care
- OPP Finance
- Exchange
- STIM Nasdaq
- OPP Nasdaq
- Market Cap
- STIM 224.8M
- OPP 199.8M
- IPO Year
- STIM 2018
- OPP N/A
- Fundamental
- Price
- STIM $3.36
- OPP $8.63
- Analyst Decision
- STIM Strong Buy
- OPP
- Analyst Count
- STIM 2
- OPP 0
- Target Price
- STIM $7.00
- OPP N/A
- AVG Volume (30 Days)
- STIM 1.5M
- OPP 108.0K
- Earning Date
- STIM 08-05-2025
- OPP 01-01-0001
- Dividend Yield
- STIM N/A
- OPP 14.41%
- EPS Growth
- STIM N/A
- OPP N/A
- EPS
- STIM N/A
- OPP N/A
- Revenue
- STIM $111,106,000.00
- OPP N/A
- Revenue This Year
- STIM $105.22
- OPP N/A
- Revenue Next Year
- STIM $11.89
- OPP N/A
- P/E Ratio
- STIM N/A
- OPP N/A
- Revenue Growth
- STIM 54.17
- OPP N/A
- 52 Week Low
- STIM $0.52
- OPP $7.26
- 52 Week High
- STIM $5.92
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- STIM 39.34
- OPP 54.45
- Support Level
- STIM $3.13
- OPP $8.50
- Resistance Level
- STIM $3.51
- OPP $8.64
- Average True Range (ATR)
- STIM 0.29
- OPP 0.08
- MACD
- STIM -0.06
- OPP -0.01
- Stochastic Oscillator
- STIM 19.49
- OPP 47.37
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.